IRIS
TOMASSINI, VALENTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.272
AS - Asia 1.907
EU - Europa 1.075
SA - Sud America 398
AF - Africa 39
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 3
Totale 6.706
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.201
SG - Singapore 1.113
CN - Cina 390
BR - Brasile 328
IE - Irlanda 272
IT - Italia 257
VN - Vietnam 164
DE - Germania 96
GB - Regno Unito 92
RU - Federazione Russa 85
SE - Svezia 84
HK - Hong Kong 53
CA - Canada 37
IN - India 37
FI - Finlandia 33
AR - Argentina 29
AT - Austria 23
JP - Giappone 23
MX - Messico 22
BD - Bangladesh 21
KR - Corea 21
ES - Italia 20
FR - Francia 18
UA - Ucraina 18
PL - Polonia 17
ZA - Sudafrica 15
TR - Turchia 14
IQ - Iraq 13
PK - Pakistan 11
AU - Australia 10
BE - Belgio 9
CZ - Repubblica Ceca 9
IR - Iran 9
NL - Olanda 9
EC - Ecuador 8
ID - Indonesia 8
PY - Paraguay 8
VE - Venezuela 8
RO - Romania 7
CL - Cile 6
LT - Lituania 5
PA - Panama 5
PE - Perù 5
AE - Emirati Arabi Uniti 4
BG - Bulgaria 4
CO - Colombia 4
KE - Kenya 4
TN - Tunisia 4
UZ - Uzbekistan 4
CH - Svizzera 3
DZ - Algeria 3
EG - Egitto 3
JM - Giamaica 3
MA - Marocco 3
AZ - Azerbaigian 2
EU - Europa 2
GA - Gabon 2
IL - Israele 2
JO - Giordania 2
KW - Kuwait 2
KZ - Kazakistan 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
OM - Oman 2
PT - Portogallo 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
UY - Uruguay 2
AL - Albania 1
AO - Angola 1
BN - Brunei Darussalam 1
CI - Costa d'Avorio 1
DK - Danimarca 1
EE - Estonia 1
GE - Georgia 1
HN - Honduras 1
HU - Ungheria 1
KH - Cambogia 1
LB - Libano 1
MC - Monaco 1
ME - Montenegro 1
ML - Mali 1
MN - Mongolia 1
NI - Nicaragua 1
NP - Nepal 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TG - Togo 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.706
Salva come PNG Salva come JPEG
Città #
Dallas 926
Singapore 862
Chandler 286
Dublin 268
Ashburn 249
Santa Clara 161
Beijing 135
The Dalles 100
Los Angeles 94
Jacksonville 84
Princeton 82
Hong Kong 53
Hefei 51
Tongling 48
Ho Chi Minh City 46
New York 45
Munich 44
Buffalo 43
Altamura 41
São Paulo 36
Dong Ket 33
Redondo Beach 31
Wilmington 29
Nuremberg 28
Rome 24
Hanoi 23
London 22
Tokyo 22
Seoul 21
Washington 21
Denver 20
Seattle 19
Brooklyn 18
Chieti 17
Boston 16
Houston 16
Montreal 16
Pescara 16
Ann Arbor 15
Helsinki 14
Milan 14
Orem 14
Romola 14
Teramo 14
Warsaw 14
Chicago 13
Stockholm 13
Chennai 12
Falls Church 12
Atlanta 11
Boardman 11
Johannesburg 11
Phoenix 11
Camerino 10
Lappeenranta 10
Moscow 10
Brussels 9
Campinas 9
Da Nang 9
Mexico City 9
Fairfield 8
Frankfurt am Main 8
Rio de Janeiro 8
Southend 8
Tehran 8
Vienna 8
Castignano 7
Haiphong 7
Mumbai 7
Poplar 7
Saint Petersburg 7
Sydney 7
Toronto 7
Turku 7
Woodbridge 7
Baghdad 6
Cardiff 6
Dhaka 6
Düsseldorf 6
Nanchang 6
Norwalk 6
Porto Alegre 6
Santander 6
Asunción 5
Belo Horizonte 5
Biên Hòa 5
Brasília 5
Istanbul 5
Naples 5
Oxford 5
Pune 5
San Francisco 5
Silvi 5
Annapolis 4
Brno 4
Carney 4
Charlotte 4
Edinburgh 4
Goiânia 4
Guangzhou 4
Totale 4.542
Salva come PNG Salva come JPEG
Nome #
"Better explanations" in multiple sclerosis diagnostic workup: A 3-year longitudinal study 126
A flow-diffusion model of oxygen transport for quantitative mapping of cerebral metabolic rate of oxygen (CMRO2) with single gas calibrated fMRI 124
A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT study 123
Contribution of metabolomics to multiple sclerosis diagnosis, prognosis and treatment 115
A multicenter survey on access to care in Multiple Sclerosis-related trigeminal neuralgia 114
Comparing MRI metrics to quantify white matter microstructural damage in multiple sclerosis 113
A cross-sectional, multicentre study of the therapeutic management of multiple sclerosis relapses in Italy 106
Cerebrovascular reactivity in multiple sclerosis is restored with reduced inflammation during immunomodulation 103
Clinical Outcomes of Escalation vs Early Intensive Disease-Modifying Therapy in Patients with Multiple Sclerosis 102
Testosterone amplifies excitotoxic damage of cultured oligodendrocytes. 100
Assessment of the Effects of Aerobic Fitness on Cerebrovascular Function in Young Adults Using Multiple Inversion Time Arterial Spin Labeling MRI 100
Neuroplasticity and motor rehabilitation in multiple sclerosis 99
Modelling the natural history of primary progressive multiple sclerosis 99
Brain morphometry in Multiple Sclerosis 98
Tractography in the presence of multiple sclerosis lesions 97
Pathophysiology of multiple sclerosis damage and repair: Linking cerebral hypoperfusion to the development of irreversible tissue loss in multiple sclerosis using magnetic resonance imaging 95
Dual-calibrated fMRI measurement of absolute cerebral metabolic rate of oxygen consumption and effective oxygen diffusivity 95
Relationship between Prolactin Plasma Levels and White Matter Volume in Women with Multiple Sclerosis 93
Oral contraceptives combined with interferon b in multiple sclerosis 92
The effect of inflammation and its reduction on brain plasticity in multiple sclerosis: MRI evidence 89
A frequency-domain machine learning method for dual-calibrated fMRI mapping of oxygen extraction fraction (OEF) and cerebral metabolic rate of oxygen consumption (CMRO 2) 89
Neurovascular Coupling During Visual Stimulation in Multiple Sclerosis: A MEG-fMRI Study 89
Neurological update: MOG antibody disease 88
Breath-hold BOLD fMRI without CO2 sampling enables estimation of venous cerebral blood volume: potential use in normalization of stimulus-evoked BOLD fMRI data 87
Case Report: Multiple Sclerosis Relapses After Vaccination Against SARS-CoV2: A Series of Clinical Cases 87
Anti-myelin antibodies predict the clinical outcome after a first episode suggestive of MS 87
Predicting the profile of increasing disability in multiple sclerosis 84
Cerebral Metabolic Changes During Visuomotor Adaptation Assessed Using Quantitative fMRI 84
A 6-year clinical and MRI follow-up study of patients with relapsing-remitting multiple sclerosis treated with Interferon-beta 82
FACS-Proteomics strategy toward extracellular vesicles single-phenotype characterization in biological fluids: exploring the role of leukocyte-derived EVs in multiple sclerosis 82
How common is truly benign MS in a UK population? 82
Defining the course of tumefactive multiple sclerosis: A large retrospective multicentre study 80
Medical education and MS: getting the training right 79
Changes of brain parenchyma free water fraction reflect tissue damage and impaired processing speed in multiple sclerosis 78
mRNA COVID-19 vaccines do not increase the short-term risk of clinical relapses in multiple sclerosis 78
Informing MS patients on treatment options: a consensus on the process of consent taking 77
Characteristics and treatment of Multiple Sclerosis-related trigeminal neuralgia: An Italian multi-centre study 77
Site-specific clinical disease onset in multiple sclerosis 76
Effect on Cognition of Estroprogestins Combined with Interferon Beta in Multiple Sclerosis: Analysis of Secondary Outcomes from a Randomised Controlled Trial 76
Lessons from immunotherapies in multiple sclerosis 75
Guillain−Barré syndrome and SARS-CoV-2 infection: a systematic review and meta-analysis on a debated issue and evidence for the ‘Italian factor’ 74
Impact of the 2017 revisions to McDonald criteria on the diagnosis of multiple sclerosis 74
Exergames for balance dysfunction in neurological disability: a meta-analysis with meta-regression 74
Age-related changes in grey and white matter structure throughout adulthood 73
Impaired Functional Connectivity Unmasked by Simple Repetitive Motor Task in Early Relapsing-Remitting Multiple Sclerosis 72
Harmonization of real-world studies in multiple sclerosis: Retrospective analysis from the rirems group 71
Diffusion-weighted imaging tractography-based parcellation of the human lateral premotor cortex identifies dorsal and ventral subregions with anatomical and functional specializations 71
Mechanisms of Network Changes in Cognitive Impairment in Multiple Sclerosis 70
Alexithymia in multiple sclerosis: relationship with fatigue and depression 68
Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study 67
Corrigendum: A Frequency-Domain Machine Learning Method for Dual-Calibrated fMRI Mapping of Oxygen Extraction Fraction (OEF) and Cerebral Metabolic Rate of Oxygen Consumption (CMRO 2) 66
Serum MMP-9/TIMP-1 and MMP-2/TIMP-2 ratios in multiple sclerosis: relationships with different magnetic resonance imaging measures of disease activity during IFN-beta-1a treatment 65
The effect of disease activity on leptin, leptin receptor and suppressor of cytokine signalling-3 expression in relapsing-remitting multiple sclerosis 64
The effect of hypointense white matter lesions on automated gray matter segmentation in multiple sclerosis 64
Neuroplasticity and functional recovery in multiple sclerosis 64
Changes in brain perfusion with training-related visuomotor improvement in MS 64
Relating brain damage to brain plasticity in patients with multiple sclerosis 63
Evidence of impaired brain activity balance after passive sensorimotor stimulation in multiple sclerosis 63
Guillain–Barré syndrome and COVID-19 vaccination: a systematic review and meta-analysis 62
Correction to: Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study 61
Endogenous retroviruses in multiple sclerosis: A network-based etiopathogenic model 61
"Back to Braak": Role of Nucleus Reuniens and Subcortical Pathways in Alzheimer's Disease Progression 60
Investigating social cognition in Multiple Sclerosis: Does Implicit Biological Motion processing affect visuo-spatial attention? 60
Similarities and differences between multiple sclerosis and type 1 diabetes 60
Thyroid autoimmunity and dysfunction in multiple sclerosis patients during long-term treatment with interferon beta or glatiramer acetate: an Italian multicenter study 59
Psychopathological and cognitive effects of therapeutic cannabinoids in multiple sclerosis: a double-blind, placebo controlled, crossover study 58
Diagnosis and management of multiple sclerosis: MRI in clinical practice 58
SARS-CoV-2 vaccination and multiple sclerosis: a large multicentric study on relapse risk after the third booster dose 57
Predictors of training-related improvement in visuomotor performance in patients with multiple sclerosis: A behavioural and MRI study 57
Monthly corticosteroids decrease neutralizing antibodies to IFNbeta1 b: a randomized trial in multiple sclerosis 57
Cannabinoid-induced effects on the nociceptive system: a neurophysiological study in patients with secondary progressive multiple sclerosis 56
Brain atrophy in relapsing-remitting multiple sclerosis: relationship with 'black holes', disease duration and clinical disability 55
Structural and functional bases for individual differences in motor learning 55
Neutralizing antibodies explain the poor clinical response to interferon beta in a small proportion of patients with multiple sclerosis: a retrospective study 55
Neutralizing and binding antibodies to IFN-beta: relative frequency in relapsing-remitting multiple sclerosis patients treated with different IFN-beta preparations 54
Progressive multifocal leukoencephalopathy or severe multiple sclerosis relapse following COVID-19 vaccine: a diagnostic challenge 54
Comparison of the effects of acetyl L-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial 53
Pronounced focal and diffuse brain damage predicts short-term disease evolution in patients with clinically isolated syndrome suggestive of multiple sclerosis 53
Motor practice promotes increased activity in brain regions structurally disconnected after subcortical stroke 52
Preservation of motor skill learning in patients with multiple sclerosis 52
Model-free characterization of brain functional networks for motor sequence learning using fMRI 52
'Gender gap' in multiple sclerosis: magnetic resonance imaging evidence 51
Distinct and overlapping functional zones in the cerebellum defined by resting state functional connectivity 49
Routine CSF parameters as predictors of disease course in multiple sclerosis: an MSBase cohort study 49
Diffusion-Weighted Imaging Tractography-Based Parcellation of the Human Parietal Cortex and Comparison with Human and Macaque Resting-State Functional Connectivity 48
Reduced brain oxygen metabolism in patients with multiple sclerosis: Evidence from dual-calibrated functional MRI 48
Relationship between emotional distress in caregivers and health status in persons with multiple sclerosis 47
A tractometry principal component analysis of white matter tract network structure and relationships with cognitive function in relapsing-remitting multiple sclerosis 47
Contemporary study of multiple sclerosis disability in South East Wales 46
Sex hormones modulate brain damage in multiple sclerosis: MRI evidence 45
Predictors of long-term clinical response to interferon beta therapy in relapsing multiple sclerosis 45
Multiple sclerosis lesions: insights from imaging techniques 44
Sex hormones: a role in the control of multiple sclerosis? 42
Post-marketing survey on clinical response to interferon beta in relapsing multiple sclerosis: the Roman experience 42
Interferon beta treatment of MS in the daily clinical setting: a 3-year post-marketing study 42
Sex hormones, brain damage and clinical course of Multiple Sclerosis 41
Transverse myelitis in children and adults 37
Real world experience with teriflunomide in multiple sclerosis: the TER-Italy study 36
Fate of neutralizing and binding antibodies to IFN beta in MS patients treated with IFN beta for 6 years 34
Targeting ASIC1 in primary progressive multiple sclerosis: evidence of neuroprotection with amiloride 29
Totale 7.070
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.395
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.395
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021102 0 0 0 0 0 29 8 14 6 5 0 40
2021/2022209 1 1 3 3 8 12 3 37 25 5 17 94
2022/2023889 76 131 41 85 70 143 57 62 100 42 46 36
2023/2024640 52 21 55 24 32 184 116 41 15 33 14 53
2024/20252.205 120 544 421 52 47 58 76 82 192 147 161 305
2025/20262.710 334 224 1.141 528 345 138 0 0 0 0 0 0
Totale 7.091